POTS Adrenergic Ab (CIHR Aims #1&2)
Postural Tachycardia SyndromeObjective: In this pilot study, we will test the hypothesis that patients with POTS (age 18-60 years) will have a higher percentage of functional antibodies to adrenergic receptors compared with control subjects without POTS.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
18 to 60
Critères de participation
Inclusion Criteria:
* Patients who have been previously diagnosed with POTS
* Control subjects (patients not diagnosed with POTS)
* Age between 18 - 60 years
* Males and Females (Give that \>80% of POTS patients are female, we will attempt to enroll a similar percentage of female control subjects)
* Able and willing to provide consent
Exclusion Criteria:
* Smokers
* Overt cause for postural tachycardia, i.e., acute dehydration
* Significant cardiovascular, pulmonary, hepatic, or hematological disease by history or prior testing
* Highly trained athletes
* Subjects with somatization or severe anxiety symptoms will be excluded
* Use of drospirenone (a spironolactone analogue) containing oral contraceptive agent
* Hypertension defined as supine resting BP\>145/95 mmHg off medications or needing antihypertensive medication
* Other factors which in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies or an unpredictable schedule
* Unable to give informed consent
Lieu de l'étude
University of Calgary
University of CalgaryCalgary, Alberta
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- University of Calgary
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT02673996